Dr. Dowling’s research is centred on developing new treatment strategies for lung cancer and understanding why different genetic subtypes of the disease respond differently to specific therapies. Her key areas of interest include cancer metabolism, immunology, KRAS-driven lung cancer, and the design of innovative three-dimensional models to advance lung cancer research.
